Lv1
10 积分 2025-08-03 加入
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
1天前
已完结
Immune checkpoint inhibitor-induced myocarditis: focus on the downstream pathogenic components and potential therapeutics
9天前
已完结
Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations
22天前
已完结
Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience
23天前
已完结
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
25天前
已完结
Loeffler’s Endocarditis: An Integrated Multimodality Approach
1个月前
已完结
Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment
8个月前
已完结
Immune checkpoint inhibitors mediate myocarditis by promoting macrophage polarization via cGAS/STING pathway
10个月前
已完结
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
10个月前
已完结
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
10个月前
已完结
皖公网安备34019202002308
